The Liquid Biopsy market within the Pharmaceuticals industry is a rapidly growing field of research and development. It is a minimally invasive procedure that uses a sample of blood to detect and monitor cancer. It is used to detect cancer at an early stage, to monitor the progression of the disease, and to assess the effectiveness of treatments. Liquid biopsy can also be used to detect genetic mutations associated with cancer, which can help guide treatment decisions. The Liquid Biopsy market is expected to grow significantly in the coming years due to its potential to improve patient outcomes and reduce healthcare costs. It is also expected to benefit from advances in technology, such as the development of more sensitive and specific tests. Some companies in the Liquid Biopsy market include Guardant Health, Exact Sciences, Biocept, and Genomic Health. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
